An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

This bill amends Pennsylvania's Controlled Substance Act to officially classify the veterinary sedative medetomidine as a Schedule III controlled substance while explicitly exempting its legitimate use in approved animal drugs and by licensed professionals. It also mandates that veterinarians store both medetomidine and xylazine under the same strict security conditions required for other controlled substances under the state Pharmacy Act. These changes directly affect veterinarians, pharmacies, and manufacturers by updating legal definitions and imposing specific storage protocols to prevent misuse of these substances.